SCHEMBL1173484

SCHEMBL1173484

C(=C(/B(c1ccccc1)c1ccccc1)c1ccccc1)\c1ccccn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.59
RAB9A P51151 5/20 0.44
NPC1 O15118 4/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
ATM Q13315 1/20 0.44
KDM4E B2RXH2 4/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOA P21397 1/20 0.39
NR4A1 P22736 1/20 0.36
USP2 O75604 1/20 0.36
ASF1A Q9Y294 1/20 0.35
POLB P06746 2/20 0.34
PKM P14618 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1173487 1.00 TDP1 (0.59) TDP1RAB9ANPC1KMT2AMEN1
SCHEMBL1173481 1.00 TDP1 (0.59) TDP1RAB9ANPC1KMT2AMEN1
SCHEMBL13176167 0.84 TDP1 (0.45) TDP1RAB9ANPC1KMT2AMEN1
SCHEMBL1173275 0.84 RAB9A (0.46) TDP1RAB9ANPC1KMT2AMEN1
SCHEMBL1173277 0.84 RAB9A (0.46) TDP1RAB9ANPC1KMT2AMEN1
SCHEMBL1173145 0.80 TDP1 (0.36) TDP1RAB9ANPC1SMN1; SMN2
SCHEMBL12884628 0.80 TDP1 (0.36) TDP1RAB9ANPC1SMN1; SMN2
SCHEMBL12885049 0.80 TDP1 (0.36) TDP1RAB9ANPC1SMN1; SMN2
SCHEMBL1173613 0.80 TDP1 (0.36) TDP1RAB9ANPC1SMN1; SMN2
SCHEMBL13176172 0.79 MAPT (0.52) TDP1RAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8436173-B2 Boron compounds, their production processes, and functional electronic devices using same KYOTO UNIVERSITY (JP) 2013-05-07 US disclosed
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME Kyoto University and Nippon Shokubai Co., LTD. 2011-02-24 US disclosed
EP-2233490-A1 NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME Kyoto University (JP) 2010-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046372-A1 NOVEL BORON COMPOUNDS, THEIR PRODUCTION PROCESSES, AND FUNCTIONAL ELECTRONIC DEVICES USING SAME ETFB, SLC40A1, SLC19A1 TDP1 3997/4885RAB9A 1304/4885NPC1 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.